Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Prostatic Neoplasms × dexamethasone 21-phosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Burkitt Lymphoma 4 Leukemia 3 Vomiting 2 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Nausea 2 Leukemia, Myeloid, Acute 2 Smoldering Multiple Myeloma 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hypersensitivity 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Delirium 1 Carcinoma, Non-Small-Cell Lung 1 Brenner Tumor 1 Blast Crisis 1

Interventions

Docetaxel 48 Prednisone 27 Leuprolide 21 enzalutamide 19 bicalutamide 15 Magnetic Resonance Spectroscopy 14 Goserelin 12 Abiraterone Acetate 12 Radiotherapy 11 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 10 abiraterone 9 cabazitaxel 8 Radiotherapy, Intensity-Modulated 8 olaparib 7 gallium 68 PSMA-11 7 Metformin 7 Ketoconazole 7 Gonadotropin-Releasing Hormone 7 Doxorubicin 7 Cyclophosphamide 7 Androgen Antagonists 7 luprolide acetate gel depot 6 Estramustine 6 pembrolizumab 5 cabozantinib 5 apalutamide 5 Radiosurgery 5 Mitoxantrone 5 Dexamethasone 5 Carboplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02491411 2018-07-12

DEXTER

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Terminated

5 enrolled 5 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡